Current role of cyanoacrylate glue transcatheter embolization in the treatment of acute nonvariceal gastrointestinal bleeding.
Fiche publication
Date publication
juin 2020
Journal
Expert review of gastroenterology & hepatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BARDOU Marc, Pr LOFFROY Romaric
Tous les auteurs :
Loffroy R, Mouillot T, Bardou M, Chevallier O
Lien Pubmed
Résumé
Over the past three decades, transcatheter arterial embolization (TAE) has become the first-line therapy for the management of acute nonvariceal gastrointestinal bleeding (NVGIB) that is refractory to endoscopic hemostasis. Advances in catheter-based techniques and newer liquid embolic agents, as well as recognition of the effectiveness of minimally invasive treatment options, have expanded the role of interventional radiology in the treatment of acute NVGIB. Many embolic agents have been used successfully. However, no guidelines exist about the choice of the best embolic agent which is still controversial. Cyanoacrylate glue has gained acceptance over time. This article aims to address the current role of TAE using cyanoacrylate glue for the treatment of acute NVGIB.
Mots clés
Acute nonvariceal upper gastrointestinal bleeding, cyanoacrylate glue, interventional radiology, lower gastrointestinal bleeding, transcatheter arterial embolization
Référence
Expert Rev Gastroenterol Hepatol. 2020 Jun 30;: